Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study

Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study

June Hong Ahn, Jin Hong Chung, Kyeong-Cheol Shin, Eun Young Choi, Hyun Jung Jin, Mi Suk Lee, Mi Jeong Nam, Kwan Ho Lee Division of Pulmonology and Allergy, Department of Internal Medicine, Yeungnam University Medical Center, College of Medicine, Yeungnam University, Daegu, South KoreaCorrespondence:...

Full description

Bibliographic Details
Main Authors:	Ahn JH, Chung JH, Shin KC, Choi EY, Jin HJ, Lee MS, Nam MJ, Lee KH
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-12-01
Series:	International Journal of COPD
Subjects:	copd inhalation therapy drug use error disease exacerbation
Online Access:	https://www.dovepress.com/critical-inhaler-handling-error-is-an-independent-risk-factor-for-freq-peer-reviewed-article-COPD

Similar Items

Comparative Study of Inhaler Device Handling Technique and Risk Factors for Critical Inhaler Errors in Korean COPD Patients
by: Jang JG, et al.
Published: (2021-04-01)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
by: Sun Hye Shin, et al.
Published: (2022-05-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
by: Vestbo J, et al.
Published: (2019-04-01)

Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study
by: Janwillem Kocks, et al.
Published: (2023-08-01)

Decline of COPD exacerbations in clinical trials over two decades – a systematic review and meta-regression
by: Stefan Andreas, et al.
Published: (2019-08-01)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
by: Miłkowska-Dymanowska J, et al.
Published: (2018-11-01)

Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler versus multiple-inhaler triple therapy: A prospective observational study in China
by: Ling Lin, et al.
Published: (2023-03-01)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
by: Jose R. Jardim, et al.
Published: (2019-04-01)

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction
by: Hyo Jin Lee, et al.
Published: (2024-01-01)

Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease
by: Sicras Mainar A, et al.
Published: (2019-09-01)

COPD Patients’ Behaviour When Involved in the Choice of Inhaler Device
by: Sorin Bivolaru, et al.
Published: (2023-05-01)

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01)

Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease
by: Krachunov Iliya, et al.
Published: (2018-12-01)

Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study
by: Ferguson GT, et al.
Published: (2020-11-01)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
by: Kerkhof M, et al.
Published: (2020-08-01)

Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators
by: Lu FY, et al.
Published: (2021-02-01)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
by: Park JW, et al.
Published: (2023-05-01)

“Frequent exacerbator” is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease
by: Tomioka R, et al.
Published: (2016-02-01)

A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management
by: Micheletto C, et al.
Published: (2019-09-01)

Impact of adherence to GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in a Swiss COPD cohort
by: Anja Jochmann, et al.
Published: (2012-03-01)

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
by: Cataldo D, et al.
Published: (2018-07-01)

Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease
by: Talman S, et al.
Published: (2021-03-01)

Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease
by: Kim EK, et al.
Published: (2024-01-01)

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
by: Whittaker H, et al.
Published: (2022-03-01)

A Prediction Scoring Model for the Effect of Withdrawal or Addition of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease
by: Lee JH, et al.
Published: (2023-02-01)

Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS
by: Martinez FJ, et al.
Published: (2021-01-01)

Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study
by: Pelaia C, et al.
Published: (2023-05-01)

Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain
by: Neches García V, et al.
Published: (2022-09-01)

“Breathing New Life Into Chronic Obstructive Pulmonary Disease (COPD)” – Results From An Online Survey Of UK Patients
by: Titmarsh S, et al.
Published: (2019-12-01)

The effects of different inhalation therapies on less symptomatic chronic obstructive pulmonary disease patients in a Chinese population: a real-world study
by: Qing Song, et al.
Published: (2023-12-01)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
by: Calverley PMA, et al.
Published: (2017-11-01)

Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis
by: Lotte C. Terpstra, et al.
Published: (2022-12-01)

An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial
by: Cahn A, et al.
Published: (2021-06-01)

Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
by: Vasbinder EC, et al.
Published: (2016-04-01)

Acute exacerbations of COPD
by: W MaxNee
Published: (2003-05-01)

The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol
by: L.C. Terpstra, et al.
Published: (2022-12-01)

A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD
by: Miravitlles M, et al.
Published: (2016-02-01)

Characterization of COPD Admissions During the First COVID-19 Outbreak
by: Cosio BG, et al.
Published: (2021-06-01)

Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease
by: van Geffen WH, et al.
Published: (2018-04-01)

Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs
by: Choi HS, et al.
Published: (2019-12-01)